{"result": "(\"entity\"<|>SAN FRANCISCO<|>GEO<|>San Francisco is a city in California where the DDW event took place in 2002.)\n##\n(\"entity\"<|>DDW<|>EVENT<|>DDW (Digestive Disease Week) is an annual event where medical professionals gather to discuss advancements in digestive diseases, held in San Francisco in 2002.)\n##\n(\"entity\"<|>LIVER INT<|>ORGANIZATION<|>Liver International is a journal that publishes research related to liver diseases, including studies on cirrhosis.)\n##\n(\"entity\"<|>WORLD J GASTROENTEROL<|>ORGANIZATION<|>World Journal of Gastroenterology is a journal that publishes articles on various aspects of gastroenterology, including liver health.)\n##\n(\"entity\"<|>EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY<|>ORGANIZATION<|>European Journal of Gastroenterology and Hepatology publishes research on liver diseases and treatments.)\n##\n(\"entity\"<|>NUTRITION IN CLINICAL PRACTICE<|>ORGANIZATION<|>Nutrition in Clinical Practice is a journal focusing on nutritional therapy and its impact on health, including liver disease.)\n##\n(\"entity\"<|>SEMINARS IN LIVER DISEASE<|>ORGANIZATION<|>Seminars in Liver Disease is a journal that provides insights into liver diseases and their management.)\n##\n(\"entity\"<|>CLINICAL NUTRITION<|>ORGANIZATION<|>Clinical Nutrition is a journal that publishes research on nutritional interventions in various health conditions, including liver disease.)\n##\n(\"relationship\"<|>DDW<|>SAN FRANCISCO<|>DDW was held in San Francisco in 2002, bringing together professionals to discuss liver disease advancements<|>7)\n##\n(\"relationship\"<|>LIVER INT<|>DDW<|>Liver International published research presented at the DDW event<|>5)\n##\n(\"relationship\"<|>WORLD J GASTROENTEROL<|>DDW<|>World Journal of Gastroenterology featured studies discussed at the DDW event<|>5)\n##\n(\"relationship\"<|>EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY<|>DDW<|>European Journal of Gastroenterology and Hepatology published findings from the DDW event<|>5)\n##\n(\"relationship\"<|>NUTRITION IN CLINICAL PRACTICE<|>DDW<|>Nutrition in Clinical Practice included articles related to liver disease discussed at the DDW<|>5)\n##\n(\"relationship\"<|>SEMINARS IN LIVER DISEASE<|>DDW<|>Seminars in Liver Disease highlighted key topics from the DDW event<|>5)\n##\n(\"relationship\"<|>CLINICAL NUTRITION<|>DDW<|>Clinical Nutrition featured research on nutritional support for liver disease presented at the DDW<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , Alkhouri N, Dasarathy S. Changes in\n138.  Lieber C S. Alcohol, liver, and nutrition. J Am Coll                 body composition after transjugular intrahepatic\n      Nutr 1991; 10:602-632.                                               portosystemic stent in cirrhosis: a critical review\n139.  Rodriguez-Keiserman D, Aranda-Michel J, Weber                        of literature. Liver Int 2011; 31:1250-1258.\n      FL Jr, et al. Bone Loss is Common in Both Choles-              155.  Tsien C, Shah SN, McCullough AJ, Dasarathy S.\n      tatic and Non-Cholestatic End Stage Liver Dis-                       Reversal of sarcopenia predicts survival after a\n      ease. DDW, San Francisco, CA, 2002.                                  transjugular     intrahepatic      portosystemic       stent.\n140.  Ukleja A, Scolapio JS, McConnell JP, et al. Nutri-                   Eur J Gastroenterol Hepatol 2013; 25:85-93.\n      tional assessment of serum and hepatic vitamin                 156.  Montano-Loza AJ. Clinical relevance of sarcope-\n      A    levels    in   patients     with     cirrhosis.     JPEN        nia in patients with cirrhosis. World J Gastroen-\n      2002;26:184-188.                                                     terol 2014; 20:8061-8071.\n141.  Scolapio J. Nutrition Therapy in Liver Disease. Nu-            157.  Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K,\n      trition in Clinical Practice 2002; 17:331.                           Ito T, Tomiyama K, Yagi S, Mori A, Uemoto S.\n142.  Shenker S, Halff G A. Nutritional therapy in alco-                   Impact of sarcopenia on survival in patients un-\n      holic fiver disease. Sem Liver Dis 1993; 13:196-                     dergoing living donor liver transplantation. Am\n      209.                                                                 JTransplant 2013; 13: 1549-1556.\n143.  Barry M, Keeling P W N, Feely J. Tissue zinc status            158.  Langer G, Großmann K, Fleischer S, et al. Nutri-\n      and drug elimination in patients with liver dis-                     tional   interventions      for   liver-transplanted      pa-\n      ease. Clin Sei 1990; 78:547-552.                                     tients. Cochrane Database Syst Rev. 2012 Aug\n144.  Thuluvath P J, Triger D R. Selenium in chronic liv-                  15; (8):CD007605.\n      er disease.J Hepatol 1992; 14:176-182.                         159.  Plevak DJ, DiCecco SR, Wiesner RH, Porayko MK,\n145.  Mohammad MK, Zhou Z, Cave M, Barve A, Mc-                            Wahlstrom HE, Janzow DJ, et al. Nutritional sup-\n      Clain CJ. Zinc and liver disease. Nutr Clin Pract.                   port for liver transplantation: identifying caloric\n      2012 Feb; 27(1):8-20.                                                and protein requirements. Mayo Clin Proc 1994;\n146.  Marchesini G, Fabbri A, Bianchi G, et al: Zinc sup-                  69: 225-30.\n      plementation and amino acid-nitrogen metabo-                   160.  Muller MJ, Loyal S, Schwarze M, Lobers J, Selberg\n      lism in patients with advanced cirrhosis. Hepatol-                   0, Ringe B, et al. Resting energy expenditure and\n      ogy 1996; 23:1084-1092.                                              nutritional state in patients with liver cirrhosis be-\n147.  Mousa N, Abdel-Razik A, Zaher A, et al. The role                     fore and after liver transplantation. Clin Nutr\n      of antioxidants and zinc in minimal hepatic en-                      1994; 13:145-52.\n      cephalopathy: a randomized trial. Therap Adv                   161.  Osaki N, Ringe B, Gubernatis G, Takada Y, Yama-\n      Gastroenterol. 2016; 9(5):684-91.                                    guchi T, Yamaoka Y,          et al.  Changes in energy\n148.  De Lédinghen V, Beau P, Mannant PR, Borderie                         substrates in relation to arterial ketone body ratio\n      C, Ripault MP, Silvain C, et al. Early feeding or                    after   human      orthotopic      liver  transplantation.\n      enteral nutrition in patients with cirrhosis after                   Surgery 1993; 113: 403-9.\n---\n                                         Tema 16.     Soporte nutricional en la hepatopatía crónica y trasplante hepático                287\n\n\n\n162.  Tsien C, Garber A, Narayanan A, Shah SN, Barnes                              years after liver transplantation. Clin Transplant\n      D, Eghtesad B, Fung J, McCullough AJ, Dasarathy\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}